An FDA-approved synthetic THC significantly reduces agitation in Alzheimer's patients, improving treatment outcomes and ...

In the United States, the likelihood of receiving a dementia diagnosis and subsequent treatment varies significantly depending on geographic location. This disparity also extends to people who are ...

Patients tolerated synthetic THC (dronabinol) well, without the adverse effects commonly associated with existing Alzheimer's ...

According to a new analysis, a mentally challenging job could slash your chances of developing dementia. The harder your brain works at your job, the less likely you may be to have memory and thinking ...